Plant ID: NPO24373
Plant Latin Name: Lobelia inflata
Taxonomy Genus: Lobelia
Taxonomy Family: Campanulaceae
NCBI TaxonomyDB:
308559
Plant-of-the-World-Online:
n.a.
Antiasthmatic; Antispasmodic; Diaphoretic; Diuretic; Emetic; Expectorant; Miscellany; Nervine
India; China
GAA; | |
CHRNA7; | |
CA2; CA1; CA7; CA4; CA6; CA12; CA9; CA14; | |
HIF1A; | |
MAPT; LMNA; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Nicotinic acetylcholine receptor | CHRNA7 | Neuronal acetylcholine receptor protein alpha-7 subunit | P36544 | CHEMBL2492 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 1.091E-06 | 1.584E-03 | CA1, CA12, CA2, CA4, CA6, CA7, CA9 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 1.688E-06 | 2.297E-03 | CA2, CA7 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 8.428E-06 | 9.176E-03 | CYP1A2, CYP2D6 |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 8.428E-06 | 9.176E-03 | CA1, CA2 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 8.609E-23 | 1.875E-18 | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 2.349E-18 | 2.557E-14 | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 2.673E-16 | 1.164E-12 | CA1, CA12, CA2, CA4, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0009820; alkaloid metabolic process | 1.179E-05 | 1.223E-02 | CYP1A2, CYP2D6 |
MF | GO:0005488; binding | GO:0043169; cation binding | 2.963E-05 | 2.688E-02 | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CHRNA7, CYP1A2, CYP2D6 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 2.460E-22 | 9.103E-21 | CA12, CA1, CA2, CA4, CA7, CA6, CA9, CA14 |
09150 Organismal Systems | 09155 Excretory system | hsa04964 | Proximal tubule bicarbonate reclamation | 1.316E-04 | 2.435E-03 | CA2, CA4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.196E-03 | 1.238E-02 | CYP2D6, CYP1A2 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.338E-03 | 1.238E-02 | CYP2D6, CYP1A2 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 1.684E-03 | 1.246E-02 | CHRNA7, CYP1A2 |
09150 Organismal Systems | 09155 Excretory system | hsa04966 | Collecting duct acid secretion | 2.007E-02 | 9.157E-02 | CA2 |
09160 Human Diseases | 09164 Substance dependence | hsa05033 | Nicotine addiction | 2.959E-02 | 9.954E-02 | CHRNA7 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 2.154E-02 | 9.157E-02 | CYP1A2 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 2.227E-02 | 9.157E-02 | GAA |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 3.745E-03 | 2.309E-02 | CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
I00-I99: Diseases of the circulatory system | Edema associated with congestive heart failure | I50, R60.9 | CA2; |
NA: NA | Edema | NA | CA2; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CYP2D6; CA2; |
I00-I99: Diseases of the circulatory system | High blood pressure | I10-I16 | CA2; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA2; |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6; |
G00-G99: Diseases of the nervous system G00-G99 | Migraine | G43 | CYP2D6; |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA2; |